Cost-Effectiveness of Rituximab in the Treatment of Diffuse Large B-Cell Non-Hodgkin's Lyphoma Patients (Dlbcl) in China
Abstract
Authors
W Chen X Xu
W Chen X Xu
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now